The intrathoracic fixation system market size has grown strongly in recent years. It will grow from $1.35 billion in 2025 to $1.46 billion in 2026 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to increasing incidence of thoracic trauma cases, rising adoption of minimally invasive surgery, advancements in thoracoscopic surgical tools, growing availability of trauma care facilities, increased surgeon training in thoracic fixation.
The intrathoracic fixation system market size is expected to see strong growth in the next few years. It will grow to $1.99 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing demand for less invasive trauma surgery, rising focus on patient recovery outcomes, expansion of advanced thoracic surgical centers, growing use of customized fixation solutions, technological improvements in fixation device materials. Major trends in the forecast period include increasing adoption of minimally invasive thoracoscopic fixation, rising demand for rib and sternal stabilization systems, growing use of low-profile fixation plates, expansion of biodegradable fixation materials, enhanced focus on faster post-surgical recovery.
The growing prevalence of thoracic disorders is expected to drive the expansion of the intrathoracic fixation system market in the coming years. Thoracic disorders include medical conditions affecting the thoracic region of the body, such as the chest area that houses the lungs, heart, esophagus, ribs, and diaphragm. The rising occurrence of these disorders is largely associated with increasing air pollution levels, which contribute to lung tissue damage and elevate the risk of chronic respiratory diseases. Intrathoracic fixation systems play a critical role in stabilizing and supporting the thoracic spine and rib cage, particularly in patients experiencing thoracic conditions such as spinal deformities, fractures, or structural instability resulting from trauma, tumors, or degenerative disorders. For example, in November 2025, according to Cancer Australia, an Australia-based government agency responsible for national cancer control, approximately 15,108 new lung cancer cases are projected to be diagnosed in Australia in 2025. Therefore, the rising prevalence of thoracic disorders is contributing to the growth of the intrathoracic fixation system market.
Leading companies operating in the intrathoracic fixation system market are concentrating on the development of innovative solutions, such as auto-contouring rib fixation systems, to enhance surgical accuracy and improve patient outcomes. Minimally invasive thoracoscopic approaches allow surgeons to stabilize rib fractures through small incisions using video-assisted techniques, which helps reduce soft tissue damage and shortens recovery time. For instance, in April 2025, Zimmer Biomet Holdings Inc., a US-based medical device company, introduced the RibFix Advantage Fixation System, the first intrathoracic rib fixation system to receive CE marking. This system incorporates a bridge design that adapts to rib anatomy during tightening and automatically contours to minimize fracture risk. It supports thoracoscopic repair with reduced tissue disruption, shorter hospital stays, and biomechanical benefits compared to conventional fixation methods.
In January 2025, Fusion Orthopedics, a US-based medical device company, acquired Metalogix for an undisclosed amount. This acquisition strengthens Fusion Orthopedics’ portfolio by adding products such as Circular Static Frames, Dynamic Frames, Delta Frames, and a forthcoming Mini-Rail System. Metalogix is a US-based medical device company recognized for its innovative external fixation systems.
Major companies operating in the intrathoracic fixation system market are Stryker Corporation, Zimmer Biomet Holdings Inc., DePuy Synthes (Johnson & Johnson), CONMED Corporation, Orthofix Medical Inc., Medacta International SA, KLS Martin Group, MicroPort Scientific Corporation, Acumed LLC, Waston Medical, B. Braun Melsungen AG, Inion Oy, Jeil Medical Corporation, Able Medical Devices, Biomet Microfixation (Zimmer Biomet), Arthrex Inc., Aesculap (B. Braun Orthopaedics), Smith & Nephew plc, RibFix Blu (Zimmer Biomet), NEUwave Medical (Johnson & Johnson), Globus Medical Inc., Integra LifeSciences Corporation, DePuy Synthes CMF, Medtronic plc.
North America was the largest region in the intrathoracic fixation system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intrathoracic fixation system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the intrathoracic fixation system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the intrathoracic fixation system market by increasing costs of imported metals, specialized polymers, precision surgical components, and minimally invasive instrumentation used in thoracic and trauma surgeries. Healthcare providers in North America and Europe are most affected due to reliance on imported fixation systems, while Asia-Pacific faces higher manufacturing costs for export-oriented devices. These tariffs are raising device acquisition costs and influencing hospital capital budgets. However, they are also promoting local manufacturing, regional supplier partnerships, and innovation in cost-effective intrathoracic fixation solutions.
The intrathoracic fixation system market research report is one of a series of new reports that provides intrathoracic fixation system market statistics, including intrathoracic fixation system industry global market size, regional shares, competitors with a intrathoracic fixation system market share, detailed intrathoracic fixation system market segments, market trends and opportunities, and any further data you may need to thrive in the intrathoracic fixation system industry. This intrathoracic fixation system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An intrathoracic fixation system is a medical device implanted through minimally invasive thoracoscopic surgery to stabilize rib fractures within the thoracic cavity. This method reduces tissue disruption and enhances recovery outcomes, offering a less invasive alternative to traditional open surgery, which helps patients experience less pain and shorter hospital stays.
The primary products in the intrathoracic fixation system market include endostaplers, thoracoscopic fixation systems, intrathoracic fixation plates, and other surgical fixation devices. Endostaplers are specialized surgical tools used in minimally invasive procedures to secure tissues, often in gastrointestinal, thoracic, or other abdominal surgeries. These devices are made from various materials, including metal, polymers, composites, and biodegradable substances, and are used in a range of applications such as thoracic, cardiovascular, and trauma surgeries. The end users of these products include hospitals, ambulatory surgical centers, surgical clinics, and research institutions.
The intrathoracic fixation system market consists of sales of intrathoracic rib fixation plates, screws, wires, and related surgical instruments. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The intrathoracic fixation system market size is expected to see strong growth in the next few years. It will grow to $1.99 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing demand for less invasive trauma surgery, rising focus on patient recovery outcomes, expansion of advanced thoracic surgical centers, growing use of customized fixation solutions, technological improvements in fixation device materials. Major trends in the forecast period include increasing adoption of minimally invasive thoracoscopic fixation, rising demand for rib and sternal stabilization systems, growing use of low-profile fixation plates, expansion of biodegradable fixation materials, enhanced focus on faster post-surgical recovery.
The growing prevalence of thoracic disorders is expected to drive the expansion of the intrathoracic fixation system market in the coming years. Thoracic disorders include medical conditions affecting the thoracic region of the body, such as the chest area that houses the lungs, heart, esophagus, ribs, and diaphragm. The rising occurrence of these disorders is largely associated with increasing air pollution levels, which contribute to lung tissue damage and elevate the risk of chronic respiratory diseases. Intrathoracic fixation systems play a critical role in stabilizing and supporting the thoracic spine and rib cage, particularly in patients experiencing thoracic conditions such as spinal deformities, fractures, or structural instability resulting from trauma, tumors, or degenerative disorders. For example, in November 2025, according to Cancer Australia, an Australia-based government agency responsible for national cancer control, approximately 15,108 new lung cancer cases are projected to be diagnosed in Australia in 2025. Therefore, the rising prevalence of thoracic disorders is contributing to the growth of the intrathoracic fixation system market.
Leading companies operating in the intrathoracic fixation system market are concentrating on the development of innovative solutions, such as auto-contouring rib fixation systems, to enhance surgical accuracy and improve patient outcomes. Minimally invasive thoracoscopic approaches allow surgeons to stabilize rib fractures through small incisions using video-assisted techniques, which helps reduce soft tissue damage and shortens recovery time. For instance, in April 2025, Zimmer Biomet Holdings Inc., a US-based medical device company, introduced the RibFix Advantage Fixation System, the first intrathoracic rib fixation system to receive CE marking. This system incorporates a bridge design that adapts to rib anatomy during tightening and automatically contours to minimize fracture risk. It supports thoracoscopic repair with reduced tissue disruption, shorter hospital stays, and biomechanical benefits compared to conventional fixation methods.
In January 2025, Fusion Orthopedics, a US-based medical device company, acquired Metalogix for an undisclosed amount. This acquisition strengthens Fusion Orthopedics’ portfolio by adding products such as Circular Static Frames, Dynamic Frames, Delta Frames, and a forthcoming Mini-Rail System. Metalogix is a US-based medical device company recognized for its innovative external fixation systems.
Major companies operating in the intrathoracic fixation system market are Stryker Corporation, Zimmer Biomet Holdings Inc., DePuy Synthes (Johnson & Johnson), CONMED Corporation, Orthofix Medical Inc., Medacta International SA, KLS Martin Group, MicroPort Scientific Corporation, Acumed LLC, Waston Medical, B. Braun Melsungen AG, Inion Oy, Jeil Medical Corporation, Able Medical Devices, Biomet Microfixation (Zimmer Biomet), Arthrex Inc., Aesculap (B. Braun Orthopaedics), Smith & Nephew plc, RibFix Blu (Zimmer Biomet), NEUwave Medical (Johnson & Johnson), Globus Medical Inc., Integra LifeSciences Corporation, DePuy Synthes CMF, Medtronic plc.
North America was the largest region in the intrathoracic fixation system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intrathoracic fixation system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the intrathoracic fixation system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the intrathoracic fixation system market by increasing costs of imported metals, specialized polymers, precision surgical components, and minimally invasive instrumentation used in thoracic and trauma surgeries. Healthcare providers in North America and Europe are most affected due to reliance on imported fixation systems, while Asia-Pacific faces higher manufacturing costs for export-oriented devices. These tariffs are raising device acquisition costs and influencing hospital capital budgets. However, they are also promoting local manufacturing, regional supplier partnerships, and innovation in cost-effective intrathoracic fixation solutions.
The intrathoracic fixation system market research report is one of a series of new reports that provides intrathoracic fixation system market statistics, including intrathoracic fixation system industry global market size, regional shares, competitors with a intrathoracic fixation system market share, detailed intrathoracic fixation system market segments, market trends and opportunities, and any further data you may need to thrive in the intrathoracic fixation system industry. This intrathoracic fixation system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An intrathoracic fixation system is a medical device implanted through minimally invasive thoracoscopic surgery to stabilize rib fractures within the thoracic cavity. This method reduces tissue disruption and enhances recovery outcomes, offering a less invasive alternative to traditional open surgery, which helps patients experience less pain and shorter hospital stays.
The primary products in the intrathoracic fixation system market include endostaplers, thoracoscopic fixation systems, intrathoracic fixation plates, and other surgical fixation devices. Endostaplers are specialized surgical tools used in minimally invasive procedures to secure tissues, often in gastrointestinal, thoracic, or other abdominal surgeries. These devices are made from various materials, including metal, polymers, composites, and biodegradable substances, and are used in a range of applications such as thoracic, cardiovascular, and trauma surgeries. The end users of these products include hospitals, ambulatory surgical centers, surgical clinics, and research institutions.
The intrathoracic fixation system market consists of sales of intrathoracic rib fixation plates, screws, wires, and related surgical instruments. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Intrathoracic Fixation System Market Characteristics
3. Intrathoracic Fixation System Market Supply Chain Analysis
4. Global Intrathoracic Fixation System Market Trends and Strategies
5. Intrathoracic Fixation System Market Analysis of End Use Industries
7. Global Intrathoracic Fixation System Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Intrathoracic Fixation System Total Addressable Market (TAM) Analysis for the Market
9. Intrathoracic Fixation System Market Segmentation
10. Intrathoracic Fixation System Market Regional and Country Analysis
11. Asia-Pacific Intrathoracic Fixation System Market
12. China Intrathoracic Fixation System Market
13. India Intrathoracic Fixation System Market
14. Japan Intrathoracic Fixation System Market
15. Australia Intrathoracic Fixation System Market
16. Indonesia Intrathoracic Fixation System Market
17. South Korea Intrathoracic Fixation System Market
18. Taiwan Intrathoracic Fixation System Market
19. South East Asia Intrathoracic Fixation System Market
20. Western Europe Intrathoracic Fixation System Market
21. UK Intrathoracic Fixation System Market
22. Germany Intrathoracic Fixation System Market
23. France Intrathoracic Fixation System Market
24. Italy Intrathoracic Fixation System Market
25. Spain Intrathoracic Fixation System Market
26. Eastern Europe Intrathoracic Fixation System Market
27. Russia Intrathoracic Fixation System Market
28. North America Intrathoracic Fixation System Market
29. USA Intrathoracic Fixation System Market
30. Canada Intrathoracic Fixation System Market
31. South America Intrathoracic Fixation System Market
32. Brazil Intrathoracic Fixation System Market
33. Middle East Intrathoracic Fixation System Market
34. Africa Intrathoracic Fixation System Market
36. Intrathoracic Fixation System Market Competitive Landscape and Company Profiles
37. Intrathoracic Fixation System Market Other Major and Innovative Companies
40. Intrathoracic Fixation System Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Intrathoracic Fixation System Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses intrathoracic fixation system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for intrathoracic fixation system? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intrathoracic fixation system market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Endostaplers; Thoracoscopic Fixation Systems; Intrathoracic Fixation Plates; Other Surgical Fixation Devices2) By Material: Metal-based Devices; Polymer-based Devices; Composite Devices; Biodegradable Materials
3) By Application: Thoracic Surgery; Trauma Surgery; Other Applications
4) By End User: Hospitals; Ambulatory Surgical Centers; Surgical Clinics; Specialized Trauma And Thoracic Centers
Subsegments:
1) By Endostaplers: Manual Endostaplers; Powered Endostaplers; Articulating Endostaplers; Reloadable Endostaplers2) By Thoracoscopic Fixation Systems: Thoracoscopic Clips; Thoracoscopic Screws and Plates; Port Access Instrumentation
3) By Intrathoracic Fixation Plates: Sternal Fixation Plates; Rib Fixation Plates; Custom Anatomical Plates; Low-Profile Plates
4) By Other Surgical Fixation Devices: Wires and Cables; Intramedullary Devices; Hybrid Fixation Kits; Absorbable Fixation Devices
Companies Mentioned: Stryker Corporation; Zimmer Biomet Holdings Inc.; DePuy Synthes (Johnson & Johnson); CONMED Corporation; Orthofix Medical Inc.; Medacta International SA; KLS Martin Group; MicroPort Scientific Corporation; Acumed LLC; Waston Medical; B. Braun Melsungen AG; Inion Oy; Jeil Medical Corporation; Able Medical Devices; Biomet Microfixation (Zimmer Biomet); Arthrex Inc.; Aesculap (B. Braun Orthopaedics); Smith & Nephew plc; RibFix Blu (Zimmer Biomet); NEUwave Medical (Johnson & Johnson); Globus Medical Inc.; Integra LifeSciences Corporation; DePuy Synthes CMF; Medtronic plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Intrathoracic Fixation System market report include:- Stryker Corporation
- Zimmer Biomet Holdings Inc.
- DePuy Synthes (Johnson & Johnson)
- CONMED Corporation
- Orthofix Medical Inc.
- Medacta International SA
- KLS Martin Group
- MicroPort Scientific Corporation
- Acumed LLC
- Waston Medical
- B. Braun Melsungen AG
- Inion Oy
- Jeil Medical Corporation
- Able Medical Devices
- Biomet Microfixation (Zimmer Biomet)
- Arthrex Inc.
- Aesculap (B. Braun Orthopaedics)
- Smith & Nephew plc
- RibFix Blu (Zimmer Biomet)
- NEUwave Medical (Johnson & Johnson)
- Globus Medical Inc.
- Integra LifeSciences Corporation
- DePuy Synthes CMF
- Medtronic plc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.46 Billion |
| Forecasted Market Value ( USD | $ 1.99 Billion |
| Compound Annual Growth Rate | 8.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
